Kirsi Bourget
Impact in
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
- Genetics top 10%
- Diabetes and associated disorders
Papers in
- Biochemistry 10
- Eicosanoids and Hypertension Pharmacology 10
-
- Mitochondrial Function and Pathology 3
- ATP Synthase and ATPases Research 3
- Peroxisome Proliferator-Activated Receptors 2
- Co-authors
- Michael T. Murray (17 shared papers)Linda S. Wicker (1 shared paper)Sarah Field (1 shared paper)Tristan Rawling (14 shared papers)Deborah J. Smyth (1 shared paper)Christopher Lowe (1 shared paper)Vincent Plagnol (1 shared paper)Rebecca Bailey (1 shared paper)
- Journals
- Biochemical Pharmacology (3 papers)Journal of Medicinal Chemistry (3 papers)ChemMedChem (2 papers)Journal of Pharmaceutical Sciences (2 papers)The International Journal of Biochemistry & Cell Biology (1 paper)
- Partner nations
- AustraliaMalaysiaUnited Kingdom
In The Last Decade
Kirsi Bourget
18 papers receiving 539 citations
Peers
Comparison fields: 5 of 66
- Biochemistry 67
- Genetics 207
- Immunology 136
- Endocrinology, Diabetes and Metabolism 90
- Cancer Research 72
Countries citing papers authored by Kirsi Bourget
This map shows the geographic impact of Kirsi Bourget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirsi Bourget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirsi Bourget more than expected).
Fields of papers citing papers by Kirsi Bourget
This network shows the impact of papers produced by Kirsi Bourget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirsi Bourget. The network helps show where Kirsi Bourget may publish in the future.
Co-authors
The 25 scholars most cited alongside Kirsi Bourget, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 333 | |
| 2 | 2017 | 33 | |
| 3 | 2017 | 32 | |
| 4 | 2014 | 31 | |
| 5 | 2012 | 27 | |
| 6 | 2017 | 25 | |
| 7 | 2020 | 24 | |
| 8 | 2021 | 12 | |
| 9 | 2018 | 8 | |
| 10 | 2018 | 8 | |
| 11 | 2013 | 6 | |
| 12 | 2019 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2021 | 2 | |
| 16 | 2024 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2025 | 1 |
About Kirsi Bourget
Kirsi Bourget is a scholar working on Biochemistry, Molecular Biology, Cancer Research, Pharmacology and Pharmacology, having authored 18 papers that have together received 556 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (10 papers), Cancer, Hypoxia, and Metabolism (7 papers), Mitochondrial Function and Pathology (3 papers), Inflammatory mediators and NSAID effects (3 papers), ATP Synthase and ATPases Research (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). The work is most often cited by research in Biochemistry (67 citations), Genetics (207 citations), Immunology (136 citations), Endocrinology, Diabetes and Metabolism (90 citations) and Cancer Research (72 citations). Kirsi Bourget has collaborated with scholars based in Australia, Malaysia and United Kingdom. Frequent co-authors include Michael T. Murray, Linda S. Wicker, Sarah Field, Tristan Rawling, Deborah J. Smyth, Christopher Lowe, Vincent Plagnol, Rebecca Bailey, David Clayton and Jason D. Cooper. Their work appears in journals such as Biochemical Pharmacology, Journal of Medicinal Chemistry, ChemMedChem, Journal of Pharmaceutical Sciences and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.